RAYMOND JAMES & ASSOCIATES - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 29 filers reported holding VIRIOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$27,744
-33.0%
30,0000.0%0.00%
Q2 2023$41,400
+275.5%
30,0000.0%0.00%
Q1 2023$11,025
+55.7%
30,0000.0%0.00%
Q4 2022$7,080
-45.5%
30,000
-14.3%
0.00%
Q3 2022$13,00035,0000.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
McCollum Christoferson Group LLC 33,300$30,7960.01%
&PARTNERS 11,000$10,1730.01%
Virtu Financial LLC 27,322$250.00%
XTX Topco Ltd 14,441$13,3550.00%
RAYMOND JAMES & ASSOCIATES 30,000$27,7440.00%
WELLS FARGO & COMPANY/MN 124$1150.00%
NORTHERN TRUST CORP 24,035$22,2280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 11,482$10,6190.00%
GEODE CAPITAL MANAGEMENT, LLC 174,469$161,3750.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders